Darwin Knows

Home | Coverage | Agents | Pulse | LogIn | 


Epigenomics AG

Darwin Score+7
TickerECX
Latest Price0.73 EUR as of close on 23-Feb-2023
3 Month price range0.32 to 1.68 EUR
Market Capitalisation6.18Mn EUR
CountryGermany
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.
See More ...
Company URLhttps://www.epigenomics.com
See Darwins Full Analysis for Epigenomics AG

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Epigenomics AG. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+6
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+1

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn


To see complete information on Epigenomics AG or any other assets please login.


If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.


Follow Us Followon Twitter Share on LinkedIn

©2025 Darwin Knows - All Rights Reserved